SCHEMBL4743862

SCHEMBL4743862

CCC/C=C/C/C=C/CCCCCCCc1cccc(O)c1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 3/20 0.62
F3 P13726 3/20 0.62
BID P55957 5/20 0.58
BCL2L1 Q07817 5/20 0.58
MCL1 Q07820 5/20 0.58
BAK1 Q16611 5/20 0.58
MMP2 P08253 2/20 0.58
KDM4E B2RXH2 1/20 0.58
MAPT P10636 1/20 0.58
ALOX15 P16050 1/20 0.58
ECE1 P42892 1/20 0.58
SGMS1 Q86VZ5 1/20 0.58
SGMS2 Q8NHU3 1/20 0.58
MUS81 Q96NY9 1/20 0.58
HSD17B10 Q99714 1/20 0.58
SAE1 Q9UBE0 1/20 0.58
EP300 Q09472 1/20 0.52
KAT2B Q92831 1/20 0.52
KAT5 Q92993 1/20 0.52
KAT8 Q9H7Z6 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19880531 1.00 F7 (0.62) F7F3BIDBCL2L1MCL1
SCHEMBL11697248 1.00 F7 (0.62) F7F3BIDBCL2L1MCL1
SCHEMBL9478710 0.94 F7 (0.70) F7F3BIDBCL2L1MCL1
SCHEMBL22847871 0.94 F7 (0.70) F7F3BIDBCL2L1MCL1
SCHEMBL29531506 0.94 F7 (0.70) F7F3BIDBCL2L1MCL1
SCHEMBL22847873 0.91 F7 (0.59) F7F3BIDBCL2L1MCL1
SCHEMBL11694798 0.91 F7 (0.68) F7F3BIDBCL2L1MCL1
SCHEMBL10532605 0.91 F7 (0.68) F7F3BIDBCL2L1MCL1
SCHEMBL19461990 0.91 BID (0.68) F7F3BIDBCL2L1MCL1
SCHEMBL19461989 0.91 BID (0.68) F7F3BIDBCL2L1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120478710-A Polysaccharide-based self-gelling powder adhered to wet tissues and preparation method thereof 上海大学 2025-08-15 CN disclosed
US-20230181674-A1 ALLERGEN PROTECTION AGAINST URUSHIOLS BEIERSDORF AG (DE) 2023-06-15 US disclosed
US-20230103675-A1 ALLERGEN PROTECTION FOR THE SKIN BEIERSDORF AG (DE) 2023-04-06 US disclosed
US-20230109157-A1 TOPICALLY APPLICABLE PREPARATION COMPRISING PEPTIDES AS ALLERGEN PROTECTION FOR THE SKIN BEIERSDORF AG (DE) 2023-04-06 US disclosed
US-20200405886-A1 PATCHES COMPRISING URUSHIOL, TEST PANELS COMPRISING THE SAME, AND METHODS OF USING THE SAME HAPTEN SCIENCES, INC. 2020-12-31 US disclosed
EP-2595229-B1 COMPOSITION, COMPOSITE PREPARED FROM THE COMPOSITION, ELECTRODE USING THE COMPOSITION OR THE COMPOSITE, COMPOSITE MEMBRANE INCLUDING THE COMPOSITE, AND FUEL CELL INCLUDING THE COMPOSITE MEMBRANE SAMSUNG ELECTRONICS CO LTD (KR) 2016-02-10 EP disclosed
US-8802315-B2 Composition, composite prepared from the composition, electrode using the composition or the composite, composite membrane including the composite, and fuel cell including the composite membrane SAMSUNG ELECTRONICS CO., LTD. (KR) 2014-08-12 US disclosed
US-8802315-B2 Composition, composite prepared from the composition, electrode using the composition or the composite, composite membrane including the composite, and fuel cell including the composite membrane SAMSUNG ELECTRONICS CO., LTD. (KR) 2014-08-12 US disclosed
US-20130122395-A1 COMPOSITION, COMPOSITE PREPARED FROM THE COMPOSITION, ELECTRODE USING THE COMPOSITION OR THE COMPOSITE, COMPOSITE MEMBRANE INCLUDING THE COMPOSITE, AND FUEL CELL INCLUDING THE COMPOSITE MEMBRANE SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-05-16 US disclosed
US-20130122395-A1 COMPOSITION, COMPOSITE PREPARED FROM THE COMPOSITION, ELECTRODE USING THE COMPOSITION OR THE COMPOSITE, COMPOSITE MEMBRANE INCLUDING THE COMPOSITE, AND FUEL CELL INCLUDING THE COMPOSITE MEMBRANE SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-05-16 US disclosed
WO-2008100977-A2 CARBAMATES THERAPEUTIC RELEASE AGENTS AS AMIDASE INHIBITORS N.V. ORGANON (NL) 2008-08-21 WO disclosed
US-4002737-A Prevention and/or treatment of poison ivy dermatitis RESEARCH CORPORATION (US) 1977-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230181674-A1 ALLERGEN PROTECTION AGAINST URUSHIOLS CPA3, TSLP, HRH2 F7 2711/4885F3 4548/4885BID 3764/4885
US-20230103675-A1 ALLERGEN PROTECTION FOR THE SKIN TSLP, CPA3, DNPEP F7 3718/4885F3 2908/4885BID 1536/4885
US-20230109157-A1 TOPICALLY APPLICABLE PREPARATION COMPRISING PEPTIDES AS ALLERGEN PROTECTION FOR THE SKIN TSLP, DNPEP, CUTA F7 886/4885F3 1985/4885BID 2640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.